CO4410175A1 - Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion - Google Patents

Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion

Info

Publication number
CO4410175A1
CO4410175A1 CO95026284A CO95026284A CO4410175A1 CO 4410175 A1 CO4410175 A1 CO 4410175A1 CO 95026284 A CO95026284 A CO 95026284A CO 95026284 A CO95026284 A CO 95026284A CO 4410175 A1 CO4410175 A1 CO 4410175A1
Authority
CO
Colombia
Prior art keywords
pct
effervent
preparation
pharmaceutical formulation
hydrophobic substance
Prior art date
Application number
CO95026284A
Other languages
English (en)
Inventor
Gerhard Gergely
Thomas Gergely
Irmgard Gergely
Original Assignee
Gerhard Gergely
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerhard Gergely filed Critical Gerhard Gergely
Publication of CO4410175A1 publication Critical patent/CO4410175A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. PREPARACION FARMACEUTICA QUE CONTEINE UN PRIN- CIPIO ACTIVO HIDROFOBO, ESPECIALMENTE LORATADINA O CISAPRIDA, UN TENSOACTIVO Y UN SISTEMA EFERVESCEN- TE, CARACTERIZADO PORQUE LA PREPARACION CONTIENE AL MENOS DOS TENSOACTIVOS O EMULSIONANTES DIFEREN- TES. 7. PROCEDIMIENTO PARA LA FABRICACION DE UN GRANU- LADO DE PRINCIPIO ACTIVO PARA UNA PREPARACION SE- GUN UNA DE LAS REIVINDICACIONES 3 A 6, CARACTERI- ZADO PORQUE UNA SOLUCION QUE CONTIENE EL PRINCIPIO ACTIVO ASI COMO PREFERENTEMENTE AL MENOS UN AGLU- TINANTE Y/O AL MENOS UN EMULSIONANTE SE APLICA SO- BRE LAS PARTICULAS DE UNA SUSTANCIA EN SUSPENSION Y/O DE UNA SUSTANCIA DE CARGA, SE DISTRIBUYE UNI- FORMEMENTE Y SE CALIENTA, DESPUES DE LO QUE EL DISOLVENTE SE SECA PREFERENTEMENTE BAJO VACIO Y EL GRANULADO ORIGINADO SE TAMIZA AL DESEADO TAMANO DE GRANOS. FIGURA 1
CO95026284A 1994-06-15 1995-06-14 Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion CO4410175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01890/94A CH686865A5 (de) 1994-06-15 1994-06-15 Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.

Publications (1)

Publication Number Publication Date
CO4410175A1 true CO4410175A1 (es) 1997-01-09

Family

ID=4221002

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95026284A CO4410175A1 (es) 1994-06-15 1995-06-14 Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion

Country Status (26)

Country Link
US (1) US5834019A (es)
EP (1) EP0768868B1 (es)
JP (1) JPH10501535A (es)
KR (1) KR100367302B1 (es)
CN (1) CN1149071C (es)
AT (1) ATE204744T1 (es)
AU (1) AU684966B2 (es)
BR (1) BR9508002A (es)
CA (1) CA2191302C (es)
CH (1) CH686865A5 (es)
CO (1) CO4410175A1 (es)
CZ (1) CZ287807B6 (es)
DE (1) DE59509566D1 (es)
ES (1) ES2161901T3 (es)
HU (1) HU221680B1 (es)
IL (1) IL114144A (es)
MX (1) MX9606391A (es)
MY (1) MY113718A (es)
NO (1) NO314016B1 (es)
NZ (1) NZ288208A (es)
PE (1) PE42295A1 (es)
PL (1) PL180135B1 (es)
SK (1) SK281262B6 (es)
TW (1) TW457097B (es)
WO (1) WO1995034284A1 (es)
ZA (1) ZA954932B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
EP0988032A1 (en) * 1997-06-11 2000-03-29 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030054036A1 (en) * 2001-03-13 2003-03-20 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
DE60220519T2 (de) * 2001-04-20 2007-09-27 The University Of British Columbia, Vancouver Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
BR0213661A (pt) * 2001-10-19 2004-10-26 Isotechnika Inc Pré-concentrado de microemulsão e método para seu preparo, formulação farmacêutica e método para seu preparo, método para produzir imuno, supressão, método para aumentar os efeitos imuno supressores de isatx247, uso de formulação farmacêutica
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
CN100381123C (zh) * 2005-01-12 2008-04-16 南京亿华药业有限公司 一种氯雷他定颗粒剂及其制法
CN101897732B (zh) * 2009-05-27 2013-01-30 北京因科瑞斯医药科技有限公司 一种中药泡腾片剂及其制备方法
CN106236713B (zh) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 一种七清败毒泡腾颗粒及其制备方法
CN107296800A (zh) * 2017-06-01 2017-10-27 江苏黄河药业股份有限公司 一种氯雷他定泡腾片及其制备方法
CN112741841A (zh) * 2019-10-29 2021-05-04 湖北真奥医药研究院有限公司 三维钙自乳化泡腾剂组合物及其制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106977B2 (ja) * 1984-12-14 1995-11-15 ゲルゲリイ、ゲルハルト 疎水性又は難溶性物質の粒子の親水化の方法
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs

Also Published As

Publication number Publication date
ZA954932B (en) 1996-02-07
DE59509566D1 (de) 2001-10-04
CA2191302C (en) 2010-08-10
ATE204744T1 (de) 2001-09-15
AU2749795A (en) 1996-01-05
ES2161901T3 (es) 2001-12-16
NZ288208A (en) 1998-08-26
NO965244D0 (no) 1996-12-09
NO965244L (no) 1997-02-13
JPH10501535A (ja) 1998-02-10
CN1149071C (zh) 2004-05-12
CH686865A5 (de) 1996-07-31
SK281262B6 (sk) 2001-01-18
MY113718A (en) 2002-05-31
HU9603452D0 (en) 1997-02-28
MX9606391A (es) 1997-07-31
IL114144A0 (en) 1995-10-31
CA2191302A1 (en) 1995-12-21
NO314016B1 (no) 2003-01-20
BR9508002A (pt) 2000-05-30
EP0768868B1 (de) 2001-08-29
SK159396A3 (en) 1997-08-06
TW457097B (en) 2001-10-01
WO1995034284A1 (de) 1995-12-21
HU221680B1 (hu) 2002-12-28
PE42295A1 (es) 1995-12-28
KR100367302B1 (ko) 2003-04-16
HUT75674A (en) 1997-05-28
CN1151693A (zh) 1997-06-11
IL114144A (en) 1999-07-14
US5834019A (en) 1998-11-10
PL180135B1 (pl) 2000-12-29
AU684966B2 (en) 1998-01-08
CZ287807B6 (en) 2001-02-14
EP0768868A1 (de) 1997-04-23
KR970703131A (ko) 1997-07-03
PL317856A1 (en) 1997-04-28
CZ367296A3 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
CO4410175A1 (es) Formulacion farmaceutica que contiene una sustancia activa hidrofobica y un sistema efervecente, y el proceso para la preparacion de la formulacion
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
ES2154737T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas.
ATE183495T1 (de) 6-dimethylaminomethyl-1-phenyl-cyclo- hexanverbindungen als pharmazeutische wirkstoffe
DE59604226D1 (de) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-olverbindungen als pharmazeutische Wirkstoffe
PT760649E (pt) Formulacoes a base de propionato de fluticasona
RU94028653A (ru) Фармацевтический препарат
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
ES2090395T3 (es) Formulados farmaceuticos gastroresistentes para administracion por via oral que contienen acidos biliares.
ES2178154T3 (es) Proceso de preparacion de formas solidas de dosificacion farmaceutica.
BR9806280A (pt) Grânulos compreendendo clavulaneto e um ou mais excipientes
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
PT86913A (pt) Processo de preparacao de sistemas droga-lipido de baixa toxicidade
FR2771292B1 (fr) Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
RU94040150A (ru) Стабильная лиофилизированная композиция тиотепа, способ ее получения
DZ2202A1 (fr) Procédé de préparation d'énantiomères purs d'acides cyclo-alcano-indol-azaindol-et pyrimido (1,2-a) indol-carbocyclique et leurs dérivés actives.
SE8302580L (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
RU94036668A (ru) Средство для лечения заболеваний полости рта
IE873091L (en) Optically active gyrase inhibitors, their preparation and¹use as antibiotics
BR9508021A (pt) Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IT1254938B (it) Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina